Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-28

FDA Approved: TERIFLUNOMIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original ANDA for teriflunomide by Mylan Pharmaceuticals, enabling the generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (generic) (teriflunomide)

Snippet

ORIG AP for TERIFLUNOMIDE (TERIFLUNOMIDE)